참고문헌
- Dotan E, Browner I, Hurria A, Denlinger C. Challenges in the management of older patients with colon cancer. J Natl Compr Canc Netw 2012;10:213-224. https://doi.org/10.6004/jnccn.2012.0020
- Feliu J, Escudero P, Llosa F, et al. Capecitabine as firstline treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study. J Clin Oncol 2005;23:3104-3111. https://doi.org/10.1200/JCO.2005.06.035
- Sun W. Evolution of capecitabine dosing in colorectal cancer. Clin Colorectal Cancer 2010;9:31-39. https://doi.org/10.3816/CCC.2010.n.004
- Andre N, Carre M, Pasquier E. Metronomics: towards personalized chemotherapy? Nat Rev Clin Oncol 2014;11:413-431. https://doi.org/10.1038/nrclinonc.2014.89
- Nannini M, Nobili E, Di Cicilia R, et al. To widen the setting of cancer patients who could benefit from metronomic capecitabine. Cancer Chemother Pharmacol 2009;64:189-193. https://doi.org/10.1007/s00280-009-0930-z
피인용 문헌
- Clinical characteristics and treatment propensity in elderly patients aged over 80 years with colorectal cancer vol.33, pp.6, 2018, https://doi.org/10.3904/kjim.2016.181